» Articles » PMID: 21873567

Quantitative Proteomic Analysis of Cellular Protein Modulation Upon Inhibition of the NEDD8-activating Enzyme by MLN4924

Overview
Date 2011 Aug 30
PMID 21873567
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Cullin-RING ubiquitin ligases (CRLs) are responsible for the ubiquitination of many cellular proteins, thereby targeting them for proteasomal degradation. In most cases the substrates of the CRLs have not been identified, although many of those that are known have cancer relevance. MLN4924, an investigational small molecule that is a potent and selective inhibitor of the Nedd8-activating enzyme (NAE), is currently being explored in Phase I clinical trials. Inhibition of Nedd8-activating enzyme by MLN4924 prevents the conjugation of cullin proteins with NEDD8, resulting in inactivation of the entire family of CRLs. We have performed stable isotope labeling with amino acids in cell culture analysis of A375 melanoma cells treated with MLN4924 to identify new CRL substrates, confidently identifying and quantitating 5122-6012 proteins per time point. Proteins such as MLX, EID1, KLF5, ORC6L, MAGEA6, MORF4L2, MRFAP1, MORF4L1, and TAX1BP1 are rapidly stabilized by MLN4924, suggesting that they are novel CRL substrates. Proteins up-regulated at later times were also identified and siRNA against their corresponding genes were used to evaluate their influence on MLN4924-induced cell death. Thirty-eight proteins were identified as being particularly important for the cytotoxicity of MLN4924. Strikingly, these proteins had roles in cell cycle, DNA damage repair, and ubiquitin transfer. Therefore, the combination of RNAi with stable isotope labeling with amino acids in cell culture provides a paradigm for understanding the mechanism of action of novel agents affecting the ubiquitin proteasome system and a path to identifying mechanistic biomarkers.

Citing Articles

Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615).

Foster J, Reid J, Minard C, Woodfield S, Denic K, Isikwei E Eur J Cancer. 2024; 209:114241.

PMID: 39096851 PMC: 11392690. DOI: 10.1016/j.ejca.2024.114241.


Diabetic sensory neuropathy and insulin resistance are induced by loss of UCHL1 in Drosophila.

Lee D, Yoon E, Ham S, Lee K, Jang H, Woo D Nat Commun. 2024; 15(1):468.

PMID: 38212312 PMC: 10784524. DOI: 10.1038/s41467-024-44747-9.


Structural and functional insights into the epigenetic regulator MRG15.

Jiang N, Li Y, Jin J, Guo J, Ding Q, Meng D Acta Pharmacol Sin. 2024; 45(5):879-889.

PMID: 38191914 PMC: 11053006. DOI: 10.1038/s41401-023-01211-6.


MLN4924 Promotes Self-Renewal of Limbal Stem Cells and Ocular Surface Restoration.

Li Q, Shen Y, Wu S, Wei H, Zou J, Xu S J Pers Med. 2023; 13(3).

PMID: 36983561 PMC: 10057348. DOI: 10.3390/jpm13030379.


Ubiquitination of NKCC2 by the cullin-RING E3 ubiquitin ligase family in the thick ascending limb of the loop of Henle.

Ares G Am J Physiol Renal Physiol. 2023; 324(3):F315-F328.

PMID: 36727946 PMC: 9988521. DOI: 10.1152/ajprenal.00079.2022.


References
1.
Tominaga K, Tominaga E, Ausserlechner M, Pereira-Smith O . The cell senescence inducing gene product MORF4 is regulated by degradation via the ubiquitin/proteasome pathway. Exp Cell Res. 2009; 316(1):92-102. PMC: 2787921. DOI: 10.1016/j.yexcr.2009.09.015. View

2.
Andrews P, He Y, Xiong Y . Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function. Oncogene. 2006; 25(33):4534-48. DOI: 10.1038/sj.onc.1209490. View

3.
Geiger T, Cox J, Ostasiewicz P, Wisniewski J, Mann M . Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat Methods. 2010; 7(5):383-5. DOI: 10.1038/nmeth.1446. View

4.
de Godoy L, Olsen J, Cox J, Nielsen M, Hubner N, Frohlich F . Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast. Nature. 2008; 455(7217):1251-4. DOI: 10.1038/nature07341. View

5.
Ongusaha P, Ouchi T, Kim K, Nytko E, Kwak J, Duda R . BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest. Oncogene. 2003; 22(24):3749-58. DOI: 10.1038/sj.onc.1206439. View